HealthcarePfizer to offer low-cost medicines, vaccines to poor nations

Pfizer to offer low-cost medicines, vaccines to poor nations


Pfizer said Wednesday that it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world’s poorest countries.

The drugmaker announced the program at the World Economic Forum’s annual gathering in Davos, Switzerland, and said it was aimed at improving health equity in 45 lower-income countries. Most of the countries are in Africa, but the list also includes Haiti, Syria, Cambodia and North Korea.

The products, which are widely available in the U.S. and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions. Company spokeswoman Pam Eisele said only a small number of the medicines and vaccines are currently available in the 45 countries.

New York-based Pfizer will charge only manufacturing costs and “minimal” distribution expenses, Eisele said. It will comply with any sanctions and all other applicable laws.

Earlier this month, the head of the World Health Organization called on Pfizer to make its COVID-19 treatment more widely available in poorer countries. Pfizer has said its COVID-19 vaccine, Comirnaty, is already being provided to poorer counties at a not-for-profit rate through the U.S. government, which buys the shots and then distributes them for free.

Comirnaty brought in nearly $37 billion in sales last year, and analysts expect the company’s COVID-19 treatment Paxlovid to add almost $24 billion this year, according to the data firm FactSet.



Original Source Link

Latest News

Nantucket grapples with who pays for climate projects and how much

Earlier this year, a waterfront house on Nantucket made headlines after its listing price plummeted 74% in the...

Bearish Wave Hits Solana: SOL Drops Below $140 – More Losses On The Horizon?

Solana, a leading blockchain platform, is experiencing a significant downturn as a persistent bearish wave sweeps through its...

Germany urges EU-China trade talks but criticises Beijing’s exports to Russia

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly...

Jabra Enhance Select 500 Review: Excellent Hearing Aids

The vast majority of additional features on the 500—including Jabra’s SoundScape speech clarity technology, top-tier support from professional...

Trump To Waste His Time Campaigning In Virginia

Instead of campaigning in a state that he has a chance of winning, Donald Trump will be campaigning...

Must Read

How to understand central bank QE losses

They are real, whether countries choose to pay...
- Advertisement -

You might also likeRELATED
Recommended to you